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Abstract 
Traditionally a diagnostic modality, ultrasound is emerging as a promising tool for non-invasive therapy, drug 
delivery, and gene therapy. The ultrasound is a mechanical wave energy generated in a medium as oscillating 
pressure in space and time at frequencies above 20 kHz, beyond the audible range. The ultrasound exposure gene-
rates bioeffects resulting in tissue heating, shear stress, and cavitation, which have been exploited for therapeutic 
applications. Ultrasound cavitation, enhanced by injected micro bubbles, perturbs cell membrane structures to 
cause sonoporation and increases the permeability to bioactive materials. Ultrasound-mediated gene delivery has 
been applied to heart, blood vessel, lung, kidney, muscle, head and neck tumour with enhanced gene transfection 
efficiency. The genes can be incorporated into microbubbles which in turn can target a specific disease site. Local 
drug delivery ensures sufficient drug concentration at the diseased region while limiting toxicity for healthy tis-
sues. Nevertheless, it has only recently become popular as a technique to enhance drug release from drug delivery 
systems. This review presents the main findings in the field of sonoporation, namely drug delivery, gene delivery 
and DNA transfer.
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Introduction
One of the major triumphs in recent times in the field of 
medicine is Sonoporation.
It is well known that sound is a form of mechanical ener-
gy that is propagated from one point to another by the in-
teraction between the neighbouring oscillating particles. 
The direction of propagation is parallel to the direction 
of oscillation. Hence, sound is defined as a longitudinal 
wave.(1) Because its propagation depends entirely on the 
creation of alternating regions of molecular compression 
and rarefaction, sound cannot exist in a vacuum.  Acous-
tic waves with frequencies between 20 Hz and ~20 KHz 
fall in the audible range. The term ultrasonic refers to 
sound waves whose frequency is greater than 20 KHz.
(1)
Its use in technological, navy and aeronautical fields 
is approximately a century old. Ultrasonic waves are 
also being used as diagnostic modalities in the medical 
field since decades but its application in the field of the-
rapeutic medicine and dentistry is new. This new and 
rapidly developing technology is bringing in a lot of 
innovations in our field and shows a lot of promise in 
achieving our aim of advancing clinical care, education, 
and scientific research. 
One such step towards this advancement having its ba-
sis in ultrasonic waves is the technique of Sonoporation. 
The purpose of this paper is to review the literature avai-
lable on sonoporation as a therapeutic aid, it’s possible 
applications and various studies done in this arena.
Definition
Sonoporation is defined as the interaction of ultrasound 
with Ultrasonic contrast agents to temporarily permeabi-
lize the cell membrane allowing for the uptake of various 
substances such as DNA, drugs, and other therapeutic 
compounds, from the extracellular environment. (2) 
This membrane alteration is transient, leaving the com-
pound trapped inside the cell after ultrasound exposure.
(3) Sonoporation, unlike other methods of transfection 
or chemotherapy, combines the capability of enhancing 
gene and drug transfer with the possibility of restricting 
this effect to the desired area and the desired time.(4) 
Thus, after exploring in vitro and in vivo studies on this 
technique, the therapeutic potential of Sonoporation as a 
promising drug delivery and gene therapy technique will 
be reviewed and evaluated in this paper.
Priniciple and Equipment
The technique of sonoporation is based on ultrasonic 
waves. The source of these waves is a piezoelectric 
crystal transducer made of lead–zirconate–titanium or 
barium titanate. These waves are produced in respon-
se to an electrical impulse in the piezoelectric crystal, 
allowing the conversion of electrical energy into me-
chanical or vibrational energy. Following the external 
perturbation, groups of molecules oscillate in phase and 
transmit their kinetic energy to nearby molecules. 
Weiman in 2002 made an apparatus for sonophoretic 
intradermal delivery of a microparticles suspension 
containing microencapsulated drugs. This device is a 
cylindrical container with one end covered with a po-
rous membrane and containing the microparticles sus-
pension. The other end has an ultrasound horn with a tip 
submerged in the microparticles suspension containing 
microencapsulated drugs.   
The ultrasound radiation is given from ultrasound ma-
chine to the microparticles suspension. The ultrasound 
radiation is applied effectively to generate cavitation 
bubbles, wherein the cavitation bubbles collapse and 
transfer their energy into the skin area thus causing the 
formation of pores in the skin area. (Fig.1)
Fig. 1 . Mechanism behind Sonoporation.(Hand drawing)
The ultrasound frequency may be 20 KHz and the ultra-
sound intensity may be in the range of 5 W/cm2 and 55 
W/cm2. The tip may have a distal end located at a distan-
ce from the membrane in the range of 1 millimeter to 10 
millimeters. The ultrasound radiation may be continuous 
or pulsed and it may be applied for a period of time in 
the range of 30 seconds to 5 minutes, preferably 1 minu-
te for continuous exposure or about 10 to 20 minutes for 
pulsed exposure with a 5% duty cycle, respectively. The 
formed pores may have a diameter in the range of 1 mi-
crometer to 100 micrometers.                                                                           
The ultrasound radiation intensity and distance from the 
skin area are also effective in generating ultrasonic jets 
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may affect transdermal transport by inducing convecti-
ve transport of the permeate across the skin, especially 
through hair follicles and sweat ducts.(1)
Mechanical effects:
At frequencies greater than 1 MHz, cavitational effects 
cease. But the other effects like generation of cyclic 
stresses because of density changes ultimately lead to 
fatigue of the medium may continue to occur. Lipid bi-
layers can easily be disordered by these stresses, resul-
ting in an increase in the permeability. Thus cavitation 
induced lipid bilayer disordering is found to be the most 
important cause for ultrasonic enhancement of transder-
mal transport.
Diagnostic ultrasound contrast agents
The sonophoresis effect will be less effective without the 
use of ultrasound contrast agents. These agents are sus-
pensions of gas bodies (stabilized micro bubbles), which 
have been designed for persistence in the circulation and 
strong echo return for imaging.(3)The interaction of ul-
trasound pulses with these gas bodies is a form of acous-
tic cavitation, and they also may act as inertial cavitation 
nuclei.(5,6)
The development of microbubbles as ultrasound con-
trast agent has opened the way for new and extended 
application of ultrasound in clinical practise as well as 
offering new search opportunities.(6)
Applications 
Gene delivery• 
Osteoinduction
Induction of dental pulp stem cell differentiation 
into odontoblasts
Site specific gene delivery 
which drive the microparticles suspension containing 
microencapsulated drugs through the porous membrane 
and the formed pores into the skin area. Now a day, the 
sonoporation devices (Fig.2) are commercially available 
by various companies. (Sonidel Limited MEMS, Texas 
Scientific Instruments, US). The normal ultrasound de-
vice can be used with certain kinds of probes. The pro-
bes are based on type of functions like nuclear transfer, 
cell fusion, tooth germ, tissues etc.
These sound waves can give its effect on formation of 
pores by possible four ways, as follows(1)-
Cavitation effects.• 
Thermal effects.• 
Induction of convective transport.• 
Mechanical effects.• 
Cavitation effect:
The cavitation is the formation of gaseous cavities in 
medium due to pressure variation in the medium caused 
by ultrasound waves. This involves both rapid growth 
and collapse of a bubble (inertial cavitation), or the slow 
oscillatory motion of a bubble in a medium (stable ca-
vitation).
Collapse of cavitation bubbles releases a shock wave 
that can cause structural alteration in the surrounding 
tissue leads to the disordering of the lipid bilayers and 
formation of aqueous channels in the skin, allowing en-
try of extracellular agents into the cytoplasm.(1)
Thermal effects:
Absorption of waves increases temperature of the me-
dium. The tissues with higher absorption coefficients, 
such as bone will experience severe thermal effects, 
compared with those with lower absorption coefficient, 
such as muscle tissues. The increase in the temperature 
of the medium varies directly with the ultrasound inten-
sity, frequency and exposure time.(1)
Convective transport:
Fluid velocities are generated in porous medium ex-
posed to ultrasound due to interference of the incident 
and reflected ultrasound waves in the diffusion cell and 
oscillations of the cavitation bubbles. Fluid velocities 
Fig. 2. Sonoporator.
Fig. 3. Basics of sonoporation
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DNA transfer
Local Drug delivery• 
Targeted Drug delivery 
Tumor cell killing• 
Induction of Apoptosis• 
Gene transduction• 
Mutant construction of bacteria• 
Gene Delivery
Gene therapy involves the introduction of a functional 
gene to replace the activity of a resident defective gene 
so that biologically active proteins can be synthesized 
within the cells whose function is to be altered.(7)
Gene therapy was initially thought to be a treatment mo-
dality for inherited single gene defects. However it has 
also found application in acquired diseases. There are 
about 4000 genetic disorders to be known yet, out of 
which 700 are in head and neck region alone.(8).Its use 
is being studied in the treatment of cancer, immunode-
ficiency diseases, cardiovascular diseases, metabolic di-
sorders, neurological disorders, hormonal disorders and 
blood factors deficiencies. It is also being developed as a 
“gene vaccine” against influenza and malaria.(7).
In gene therapy it is very important to develop an effec-
tive and safe gene delivery system. Hence in advance-
ment in this arena, Sonoporation induced gene transfer 
with the help of ultrasound contrast agents was found as 
an innovative method.
Its applications in field of oral medicine may act as an 
eye opener for oral physicians who are not familiar with 
this life altering technique.
 Its applications are as follows-
Osteoinduction:
Bone morphogenetic protein is believed to participate in 
bone healing and regeneration. Gene transfer approach 
is a promising option for utilizing Bone morphogenic 
protein.  
Osawa K et al(9) in Japan in 2009 used a plasmid-based 
human BMP-2 construct (pCAGGS-BMP-2) and exa-
mined the induction of bone in the skeletal muscle of 
mice. The BMP-2 gene was transferred into the skeletal 
muscle of mice by transcutaneous sonoporation and was 
assessed by various methods confirming that transcuta-
neous sonoporation with pCAGGS-BMP-2 caused oste-
oinduction in the skeletal muscle of mice. 
These results suggest the possibility of the effective 
clinical use of human BMP-2 gene therapy in clinical 
applications.(9)
Induction of dental pulp stem cell differentiation into 
odontoblasts: 
The long-term goal of dental treatment is to preserve tee-
th and prolong their function. The dream of the dentist 
is to restore the lost tooth structure by natural healing is 
an unfulfilled dream. But this technique has shown some 
light in this dream which in future will definitely beco-
me possible and will possibly allow the natural complete 
restoration of teeth.      
Misako Nakashima et al (10) in 2003 in Japan studied 
that gene therapy has the potential to induce reparative 
dentin formation for potential pulp capping. The growth/
differentiation factor 11 (GDF11), a morphogen, could 
enhance the healing potential of pulp tissue to induce 
differentiation of pulp stem cells into odontoblasts by 
sonoporation- mediated gene delivery. Recombinant hu-
man GDF11 induced the expression of dentin sialopro-
tein (Dsp), a differentiation marker for odontoblasts, in 
mouse dental papilla mesenchyme in organ culture.(10) 
The in vivo transfer of Gdf11 by sonoporation stimula-
ted the reparative dentin formation during pulpal wound 
healing in canine teeth. 
These results provide the scientific basis and rationale 
for gene therapy in endodontic treatment and dentistry.
Site specific gene delivery:  
In gene therapy, it is important to develop an effecti-
ve and safe gene delivery system.  Gene transfer at the 
required specific site is essential for reducing the side 
effects, Gene expression was observed only at site of 
ultrasound exposure.(11) Ultrasound is a very effective 
modality for drug delivery and gene therapy because 
energy that is non-invasively transmitted through the 
skin can be focused deeply into the human body in a spe-
cific location and employed to release drugs at that site. 
Ultrasound-mediated gene delivery has been applied 
to heart, blood vessel, lung, kidney, muscle, brain, and 
tumour with enhanced gene transfection efficiency.(12) 
Moreover, this method was more efficient than the con-
ventional lipofection method.
Shozo sonoda et al (13) in  Japan in 2006 significantly 
tried  gene transfer to corneal epithelium and keratocytes 
mediated by ultrasound with microbubbles and conclud-
ed that ultrasound with microbubbles greatly increases 
gene transfer to in vivo and in vitro corneal cells.  This 
noninvasive gene transfer method may be a useful tool 
for clinical gene therapy.
DNA transfer:
Delivery of nucleic acid to a target tissue together with a 
means of facilitating  efficient entry of nucleic acid into 
cell populations of that tissue remain amongst the princi-
ple challenges to effective gene therapy in the treatment 
of a variety of disorders including cancer, cardiovas-
cular disease and inherited immune deficiencies. The 
development of nonviral gene transfer methods would 
be a valuable addition to the gene- therapy armamen-
tarium, particularly for localized targeting of specific 
tissue volume.(4) Ultrasound can produce a variety of 
non-thermal bioeffects via acoustic cavitation including 
DNA delivery.  
Studies have shown ultrasound enhancement of DNA 
delivery over direct injection, lipofection, and even over 
viral transfection.
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Lawrie et al  (14) delivered luciferase marker plasmid 
in porcine vascular smooth muscle cells  with naked or 
lipid-charged DNA with or without ultrasound exposure 
.The ultrasound application enhanced subsequent lucife-
rase expression by 7.5 times for naked DNA, 2.4 times 
for lipid-charged DNA in the muscle cells.
The in vivo treatment of cardiovascular problems with 
help of sonoporation has also been recently reported. 
The studies done by Taniyama et al. (15) and Yamasa-
ki et al   addressed the possibility of preventing vascu-
lar proliferation i.e restenosis after angioplasty. These 
effects are basically seen in those vessels which has been 
isonated.(16)
Administration of Drugs
Transdermal drug delivery offers an attractive alterna-
tive to the conventional drug delivery methods of oral 
administration and injection. 
The drugs that can be delivered are NSAIDS, anaesthe-
tics, antibiotics, anti-cancer drugs, corticosteroids, insu-
lin and vasodilators.(1) All these drugs have increased 
penetrance  and effect with application of sonoporation 
technique.
Drugs can be incorporated into microbubbles, which in 
turn can target a specific disease site using ligands such 
as the antibody. Drugs can be released ultrasonically 
from microbubbles that are sufficiently robust to circu-
late in the blood and retain their cargo of drugs until they 
enter an insonated volume of tissue. Local drug delivery 
ensures sufficient drug concentration at the diseased re-
gion while limiting toxicity for healthy tissues.(11)
The increase in ultrasound intensity leads to proportional 
increase in drug transport. The intensity most commonly 
used was 0.5 to 3.0 W/cm2.
Advantages(1)-
1) Allowed strict control of transdermal penetration 
rates. 
2) Less anxiety provoking and less painful then injec-
tions. 
3) It also allows greater patient satisfaction.
4) Less systemic absorption. 
5) The drugs given were less immunological sensiti-
zing.
Tumor Cell Killing 
Ultrasound-mediated destruction of microbubbles has 
been proposed as an innovative non-invasive drug de-
livery system for cancer therapy. This will not act only 
by killing the cells but can give a new favourable look to 
chemotherapy over other treatment options. The patient 
will be saved from adverse effects of anticancer drugs 
which usually act as double edged swords.(17)  (Loreto 
B Feril et al, 2002)  
The K. Iwanga et al(18) in 2007 in Japan studied the 
efficiency of sonoporation   toward growth inhibition of 
human gingival squamous carcinoma cells in vitro and 
in vivo. The Ca9-22, a human gingival squamous carci-
noma cell line was used in this study. Sonoporation was 
used to deliver bleomycin and transfect a cdtB-expres-
sing plasmid into Ca9-22 cells in vitro and in vivo.
The results showed that tumors nearly disappeared in 
Ca9-22 cell-implanted treated with bleomycin or cdtB-
expressing plasmid during the 4-week experimental pe-
riod.(18)
Takagi Hironobu et al in 2009 in Japan administered a 
low dose of bleomycin (BLM) by sonoporation with the 
anti-EGFR antibody producing a marked growth inhibi-
tion of Ca9-22 cells in vitro. (19)
These findings indicate that sonoporation makes it pos-
sible to administer drugs into cells more efficiently and 
specifically, suggesting a novel application for treatment 
of oral squamous cell carcinoma.
Induction of Apoptosis
Apoptosis is an organized process of cell death, which 
occurs naturally for unneeded
cells. This process may be used in future for killing can-
cerous cells and other cells of benign growths before 
malignant change or size reduction of the growth before 
surgeries. 
Ashush et al. 2000 (20) and Ando et al in 2006 (21) 
concluded that exposure of cells to ultrasonic cavitation 
was shown to induce apoptosis in addition to the con-
ventionally reported instantaneous cell lysis and necro-
tic disintegration. The induction of apoptosis by 1 MHZ 
ultrasound exposure has been directly linked to inertial 
cavitation by its dependence on the presence of an ultra-
sound contrast agent(22).
Gene Transduction
Gene transduction technologies are essential tools for 
understanding of gene functions. Sonoporation is carried 
out with relatively simple procedures and easily trans-
duces genes into mesenchymal cells without significant 
damage to target tissues.(23)Therefore, sonoporation is 
effective for gene transduction to study the molecular 
mechanisms of morphogenesis.
Sho Ohta et al in 2007 in Japan conducted a study on 
gene transduction by sonoporation on chick embryos. 
The survival rates for sonoporated embryos was 96 % 
after 24-48 hrs and 60 % after 7 days.(23)
Mutant Constuction of Bacteria
The study of genetic structure growth of microorga-
nisms was often hindered due to lack of genetic tools. 
The construction of allelic-exchange mutants is essential 
for understanding the gene functions. Also this techni-
que helped in producing double crossovers in a single 
step which was not feasible with conventional procedu-
res like electroporation and conjugation. The unique fea-
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tures of one-step double crossovers obtained using intact 
plasmids signify sonoporation as a potentially powerful 
genetic tool for streamlining mutant construction.(24)
Drawbacks
With so many advantages, the negative effects of this 
technique are minimal. The process may be time consu-
ming. Minor tingling, irritation, and burning have been 
reported  at site of application.(1)
Discussion
Ultrasound waves were initially only used as a mean of 
diagnostic aid. It took much longer time to give new di-
rection to these waves to use them as a possible mean 
of life saving method. The results are creating scientific 
interest in the therapeutic field of medicine and dentistry. 
With this technique it will be possible to control major 
hereditary problems and treat malignancies, thus saving 
many lives. Sonoporation, just a small vibration force 
has the power to innovate new treatment methods with 
wide applications. Though this is still in the infancy sta-
ge, it holds a promising and great future prospective. 
The sonoporation mediated gene transfer technique was 
also evaluated for transfection efficiency and safety for 
gene delivery in comparison with other methods. The 
results concluded that Sonoporation gene therapy might 
be the safest technique to be used in actual clinical prac-
tice.(4)
Theoretically, sonoporation could help deliver genes 
with high spatial and temporal specificity. The impor-
tance of selective targeting in gene therapy cannot be 
overemphasized, considering the risks associated with 
systemic delivery of genetic vectors at high doses. The 
development of “smart” bubbles that can recognize and 
attach to specific targets might enhance the spatial reso-
lution even further, providing a real “ZIP code based” 
delivery of genetic material
Sonoporation has not just enhanced the penetration of 
drugs at desired amounts and at desired times but also 
has opened a path for sonophoretic delivery of peptides 
and protein drugs.(1) Moreover the exact delivery of 
cytotoxic drugs into specific tumor sites will not just kill 
the bud in the nip but will also save normal body cells 
from the toxic side effects of therapeutic drugs. 
Thus in coming ages, ultrasound mediated sonoporation 
is going to gain importance  in the therapeutic field of 
medicine and dentistry along with diagnostic arena and 
will give new ray of hope of life.
 
Conclusion
While in the race of advancing technology, this new 
avatar of century old ultrasound technique is likely to 
serve as a boom in the field of diagnosis and therapeutic 
dentistry. With  so many applications with minimal need 
of equipment, this emerging new form of sound energy 
will revolutionise many forms of treatment .This possi-
bility to transfer therapeutic genes would be a new tool 
for infancy gene therapy and will take research to new 
heights. Thus, its simplicity and non invasiveness may 
provide a new avenue for microinjecting various subs-
tances into a wide range of living tissues. With this we 
can envision a whole gamut of newer technologies and 
products in the foreseeable future dentistry.
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